Arrowhead Pharmaceuticals Inc (ARWR)
18.96
-0.57
(-2.92%)
USD |
NASDAQ |
Dec 27, 16:00
18.88
-0.08
(-0.42%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Research and Development Expense (Quarterly): 135.83M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 224.48M |
| Amgen Inc | 1.45B |
| Vertex Pharmaceuticals Inc | 875.90M |
| Avidity Biosciences Inc | 77.20M |
| Harmony Biosciences Holdings Inc | 25.39M |